WCN26-3443 ARTIFICIAL INTELLIGENCE DISCOVERS A NOVEL MACROPHAGE-MYOFIBROBLAST TRANSITION INHIBITOR FOR TARGETING THE MACROPHAGE-DRIVEN CHRONIC RENAL FAILURE

Read full text Summarise with VIRAT
Authors: Jeff Yat‐Fai Chung, Philip Chiu‐Tsun Tang, Max Kam‐Kwan Chan, David J. Nikolic‐Paterson, Hui-Yao Lan, Sydney Chi-Wai TANG, Patrick Ming‐Kuen Tang
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic kidney disease (CKD) is a leading global cause of mortality, often linked with non-communicable diseases such as diabetes, cardiovascular disease, and cancer. Effective treatments to halt kidney fibrosis remain lacking. Macrophage–Myofibroblast Transition (MMT) is a critical driver of CKD progression. This study aimed to develop a novel therapeutic strategy targeting MMT by inhibiting its key regulator, the neuronal transcription factor Pou4f1.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Cardiac Fibrosis and Remodeling Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104439–104439
Publication date
25 March 2026
Language
EN